Zdrowie i gospodarka · 02/04/2019
FDA Continues Regulatory Project Management Site Tours and Interaction Program for Pharmaceutical Companies
The FDA's CDER is extending its Regulatory Project Management Site Tours and Regulatory Interaction Program, inviting pharmaceutical companies to participate by contacting CDER
Source: Federal Register — Food and Drug AdministrationOpen original release →